DELAWARE
|
|
33-0824714
|
(State
of jurisdiction of Incorporation)
|
|
(I.R.S.
Employer Identification No.)
|
|
|
|
8885
REHCO RD. SAN DIEGO, CA
|
|
92121
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
·
|
2
ea
8 ft Laminar Flow Hoods
|
·
|
Labgard
Laminar Flow Hood 8 ft
|
·
|
Isotemp
Laboratory Refrigerator
|
·
|
Jaun
Freezer 80
|
·
|
Centrifuge
5417 C
|
·
|
Beckman
Allegra GR Centrifuge
|
·
|
Baxter
Incubator
|
·
|
Jouan
Floor Centrifuge
|
·
|
EIO
Microscope
|
·
|
Mettler
Toledo PR 5002 Scale
|
·
|
Biohazard
Dry Keeper
|
·
|
Bigger
Bill Thermolyne
|
·
|
Isotemp
220 Bath
|
·
|
2128
Fraction Collector
|
·
|
10
ea - Lab Chairs
|
·
|
A
K-Series LN2 Storage Tank was installed in our Cryo Contaminate
Lab
|
·
|
A
Centrifuge was installed in Class 10,000 Clean
Room
|
·
|
A
Contract signed with Pegasus Building Services for Lab Cleaning
Services
|
·
|
A
Cryo 300 LN2 Storage System installed in Main Cryo
Lab
|
·
|
A
CryoPlus 1 LN2 Storage System installed in Main
Lab
|
·
|
2
ea
Dry Shippers with shipping cases were received for Cryo
Labs
|
·
|
2
ea
Oxygen Deficiency Monitors were
Received
|
·
|
A
Computer system with software for Cryo lab
received
|
·
|
A
Temperature & Humidity Data Logger was ordered on November
14
|
·
|
A
CBS Controlled Rate Freezer was ordered on November
26
|
October
1, 2005 to September 30, 2006
|
High
|
Low
|
First
Quarter
|
3.00
|
3.00
|
Second
Quarter
|
3.00
|
1.50
|
Third
Quarter
|
3.05
|
1.01
|
Fourth
Quarter
|
3.20
|
1.25
|
October
1, 2006 to September 30, 2007
|
|
|
First
Quarter
|
2.00
|
.36
|
Second
Quarter
|
.80
|
.50
|
Third
Quarter
|
1.20
|
.50
|
Fourth
Quarter
|
.18
|
.69
|
Laboratory
information systems
|
|
$
|
30,000
|
|
Laminar
flow hoods (2 ea) 4ft
|
|
$
|
10,000
|
|
Sepax
Cell Separation Device
|
|
$
|
50,000
|
|
Blood
processing equipment
|
|
$
|
80,000
|
|
Bar
code labeling equipment
|
|
$
|
3,000
|
|
Tube
heat sealers (2 ea)
|
|
$
|
4,000
|
|
Bench
top centrifuges (2) refrigerated
|
|
$
|
12,000
|
|
Cell
Therapy Software
|
|
$
|
30,000
|
|
Cryo
Tracking Software
|
|
$
|
28,000
|
|
Cryo
Tracking Equipment
|
|
$
|
45,000
|
|
Hematology
analyzer
|
|
$
|
25,000
|
|
Flow
Cytometer
|
|
$
|
175,000
|
|
BacTec
Microbiology equipment
|
|
$
|
20,000
|
|
Small
equipment (lab set-up)
|
|
$
|
10,000
|
|
Microscope
|
|
$
|
5,000
|
|
CO2
Incubator
|
|
$
|
4,000
|
|
Lab
benches
|
|
$
|
30,000
|
|
Supplies
/ reagents*
|
|
$
|
100,000
|
|
Total
|
|
$
|
661,000
|
|
Computer
system / Lab & offices
|
|
$
|
100,000
|
|
Medical
Software
|
|
$
|
45,000
|
|
Misc
equipment
|
|
$
|
30,000
|
|
Phone
system
|
|
$
|
30,000
|
|
Back-up
generator
|
|
$
|
50,000
|
|
Security
system
|
|
$
|
20,000
|
|
Total
|
|
$
|
275,000
|
|
Director of
Labs
|
|
$
|
120,000
|
|
Director of
Quality & Assurance
|
|
$
|
75,000
|
|
Adm.
Director
|
|
$
|
75,000
|
|
Dir.
Of Engineering / Production
|
|
$
|
85,000
|
|
Lab
Tech
|
|
$
|
65,000
|
|
Lab
Tech
|
|
$
|
65,000
|
|
Customer
Service Representative.
|
|
$
|
45,000
|
|
Director
of Market & Sales
|
|
$
|
100,000
|
|
Facility
Manager / Receiving & Shipping
|
|
$
|
60,000
|
|
Support
Staff
|
|
$
|
50,000
|
|
Total
|
|
$
|
740,000
|
|
BIO-MATRIX
SCIENTIFIC GROUP, INC.
|
||||||||
(Formerly
Tasco International, Inc.)
|
||||||||
(A
Development Stage Company)
|
||||||||
Balance
Sheet
|
||||||||
|
||||||||
ASSETS
|
||||||||
As
of
September
30, 2007
|
As
of
September
30, 2006
|
|||||||
CURRENT ASSETS | ||||||||
Cash | $ |
44,110
|
$ |
22,641
|
||||
Pre-paid Expenses |
11,298
|
20,207
|
||||||
Total
Current Assets
|
55,408
|
42,848
|
||||||
PROPERTY & EQUIPMENT |
365,323
|
340,557
|
||||||
GOODWILL | ||||||||
Intangible Assets/Technology | ||||||||
Total Other Assets |
23,092
|
29,127
|
||||||
TOTAL ASSETS | $ |
443,823
|
$ |
412,532
|
||||
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES | ||||||||
Bank overdraft |
11,534
|
|||||||
Accounts payable | $ |
9,015
|
$ |
91,079
|
||||
Loans from former parent |
-
|
1,195,196
|
||||||
Notes Payable |
41,609
|
148,952
|
||||||
Accrued Payroll |
12,000
|
-
|
||||||
Accrued Payroll Taxes |
30,181
|
4,983
|
||||||
Accrued Interest |
2,858
|
1,368
|
||||||
Accrued expenses |
-
|
11,477
|
||||||
Total
Current Liabilities
|
$ |
107,197
|
$ |
1,453,055
|
||||
LONG TERM LIABILITIES |
-
|
-
|
||||||
TOTAL LIABILITIES | $ |
107,997
|
$ |
1,453,055
|
||||
STOCKHOLDERS' EQUITY |
Common Stock, ($.0000 par value) | ||||||||
authorized 80,000,000 shares authorized; 13,385,000 and 23,229,396 shares issued and outstanding | ||||||||
as of September 30, 2006 and September 30, 2007, respectively |
2,323
|
1,339
|
||||||
Additional paid-in Capital |
5,208,244
|
1,379,332
|
||||||
Deficit accumulated during the development stage | (4,873,941 | ) | (2,421,194 | ) | ||||
Total Stockholders' Equity (Deficit) | $ |
336,626
|
$ | (1,040,523 | ) | |||
TOTAL LIABILITIES | ||||||||
& STOCKHOLDERS' EQUITY | $ |
432,823
|
$ |
412,532
|
||||
BIO-MATRIX
SCIENTIFIC GROUP, INC.
|
||||||||||||
(Formerly
Tasco International, Inc.)
|
||||||||||||
Statements
of Operations
|
||||||||||||
|
||||||||||||
August
2, 2005
|
||||||||||||
(inception)
|
||||||||||||
12
Months Ended
|
9
Months Ended
|
Through
|
||||||||||
Sept
30,
|
Sept
30,
|
Sept
30,
|
||||||||||
2007
|
2006
|
2007
|
||||||||||
|
|
|
||||||||||
REVENUES
|
||||||||||||
Sales
|
$ |
-
|
-
|
$ |
-
|
|||||||
Total
Revenues
|
||||||||||||
COSTS
AND EXPENSES
|
||||||||||||
Research
and Development
|
261,077
|
75,453
|
471,917
|
|||||||||
General
and administrative
|
1,131,756
|
1,138,364
|
2,456,322
|
|||||||||
Depreciation
and amortization
|
1,333
|
742
|
2,215
|
|||||||||
Consulting
and professional fees
|
1,035,177
|
801,635
|
1,882,866
|
|||||||||
Impairment
of intangibles
|
0
|
34,688
|
34,688
|
|||||||||
Total
Costs and Expenses
|
2,429,343
|
2,050,882
|
4,848,008
|
|||||||||
OPERATING
LOSS
|
(2,429,343 | ) | (2,050,882 | ) | (4,848,008 | ) | ||||||
OTHER
INCOME & (EXPENSES)
|
||||||||||||
Interest
Expense
|
(23,636 | ) | (2,367 | ) | (26,165 | ) | ||||||
Other
Expense
|
(74 | ) |
-
|
(74 | ) | |||||||
Interest
Income
|
306
|
-
|
306
|
|||||||||
Total
Other Income & (Expenses)
|
(23,404 | ) | (2,367 | ) | (25,933 | ) | ||||||
NET
INCOME (LOSS)
|
$ | (2,452,747 | ) | (2,053,249 | ) | $ | (4,873,941 | ) | ||||
BASIC
AND DILUTED EARNINGS (LOSS) PER SHARE
|
||||||||||||
BASIC
AND DILUTED EARNINGS (LOSS) PER SHARE
|
$ | (0.13 | ) | $ | (0.19 | ) | ||||||
WEIGHTED
AVERAGE NUMBER OF
|
||||||||||||
COMMON
SHARES OUTSTANDING
|
18,397,245
|
10,960,440
|
||||||||||
BIO-MATRIX
SCIENTIFIC GROUP INC. AND SUBSIDIARY
|
|||||
(FORMERLY
TASCO INTERNATIONAL, INC.)
|
|||||
Consolidated
Statement of Stockholders' Equity
|
|||||
From
August 2, 2005 through September 30, 2007
|
|||||
|
|
|
|
||
|
|
|
Additional
|
|
|
|
Common
|
Paid-in
|
Retained
|
|
|
|
Shares
|
Amount
|
Capital
|
Earnings
|
Total
|
|
|
|
|
|
|
Shares
issued to parent
|
25,000
|
35,921
|
-
|
35,921
|
|
Net
Loss August 2, 2005
|
|||||
through
September 30, 2005
|
|
|
|
(1,000)
|
(1,000)
|
Balance
September 30, 2005
|
25,000
|
35,921
|
-
|
(1,000)
|
34,921
|
Net
Loss October 1, 2005
|
|||||
through
December 31, 2005
|
(366,945)
|
(366,945)
|
|||
Balance
December 31, 2005
|
25,000
|
35,921
|
-
|
(367,945)
|
(332,024)
|
Recapitalization
|
9,975,000
|
(34,921)
|
34,921
|
-
|
|
Stock
issued Tasco merger
|
2,780,000
|
278
|
(278)
|
-
|
|
Stock
issued for services
|
305,000
|
31
|
759,719
|
759,750
|
|
Stock
issued for Compensation
|
300,000
|
30
|
584,970
|
585,000
|
|
Net
Loss January 1, 2006
|
|||||
through
September 30, 2006
|
(2,053,249)
|
(2,053,249)
|
|||
Balance
September 30, 2006
|
13,385,000
|
1,339
|
1,379,332
|
(2,421,194)
|
(1,040,523)
|
Stock
issued for services
|
2,118,623
|
212
|
974,580
|
974,792
|
|
Stock
issued for Compensation
|
547,620
|
55
|
325,291
|
325,346
|
|
Stock
issued for Cash
|
1,940,666
|
195
|
484,972
|
485,167
|
|
Stock
issued in exchange for canceling debt
|
5,237,487
|
523
|
2,044,069
|
2,044,592
|
|
Net
Loss October 1, 2006
|
|||||
through
September 30, 2007
|
(2,452,747)
|
(2,452,747)
|
|||
Balance
September 30, 2007
|
23,229,396
|
2,323
|
5,208,244
|
(4,873,941)
|
336,626
|
BIO-MATRIX
SCIENTIFIC GROUP, INC. AND SUBSIDIARY
|
||||||||||||
(FORMERLY
TASCO INTERNATIONAL, INC.)
|
||||||||||||
(
A Development stage Company)
|
||||||||||||
Consolidated
Statements of Cash Flows
|
||||||||||||
|
||||||||||||
August
2, 2005
|
||||||||||||
(inception)
|
||||||||||||
12
Months Ended
|
9
Months Ended
|
through
|
||||||||||
Sept
30,
|
Sept
30,
|
Sept
30,
|
||||||||||
2007
|
2006
|
2007
|
||||||||||
|
|
|
||||||||||
CASH
FLOWS FROM OPERATING ACTIVITIES
|
||||||||||||
Net
(loss)
|
$ | (2,452,747 | ) | $ | (2,053,249 | ) | $ | (4,873,941 | ) | |||
Adjustments
to reconcile net loss to net cash (used in) provided
|
||||||||||||
by
operating activities:
|
||||||||||||
Depreciation
expense
|
1,333
|
742
|
2,215
|
|||||||||
Stock
issued for compensation
|
325,344
|
585,000
|
910,344
|
|||||||||
Stock
issued for services
|
974,792
|
759,750
|
1,734,542
|
|||||||||
Changes
in operating assets and liabilities:
|
||||||||||||
(Increase)
decrease in prepaid expenses
|
8,909
|
(15,074 | ) | (11,298 | ) | |||||||
Increase
(Decrease) in accounts payable
|
(82,064 | ) |
67,878
|
9,015
|
||||||||
Increase
(Decrease) in accrued expenses
|
57,155
|
15,799
|
74,983
|
|||||||||
Net
Cash Provided by (Used in) Operating
Activities
|
(1,167,278 | ) | (639,154 | ) | (2,154,140 | ) | ||||||
CASH
FLOWS FROM INVESTING ACTIVITIES
|
||||||||||||
(
Increase) Decrease in deposits
|
6,035
|
-
|
(23,092 | ) | ||||||||
Purchases
of fixed assets
|
(26,100 | ) | (237,874 | ) | (367,539 | ) | ||||||
Net
Cash Provided by (Used in) Investing
Activities
|
(20,065 | ) | (237,874 | ) | (390,631 | ) | ||||||
CASH
FLOWS FROM FINANCING ACTIVITIES
|
||||||||||||
Increase
(Decrease) in bank overdraft
|
11,534
|
-
|
11,534
|
|||||||||
Common
stock issued for cash
|
194
|
-
|
1,472
|
|||||||||
Additional
paid in capital
|
484,972
|
519,615
|
||||||||||
Principal
borrowings on notes
|
712,112
|
148,952
|
861,064
|
|||||||||
Net
borrowings from related parties
|
-
|
750,450
|
1,195,196
|
|||||||||
Net
Cash Provided by (Used in) Financing
Activities
|
1,208,812
|
899,402
|
2,588,881
|
|||||||||
Net
Increase (Decrease) in Cash
|
21,469
|
22,374
|
44,110
|
|||||||||
Cash
at Beginning of Period
|
22,641
|
267
|
-
|
|||||||||
Cash
at End of Period
|
$ |
44,110
|
22,641
|
44,110
|
||||||||
|
||||||||||||
Significant
non-cash activities:
|
||||||||||||
Stock
issued to cancel debt
|
$ |
2,044,592
|
$ |
-
|
$ |
2,044,592
|
||||||
Total
|
2,044,592
|
-
|
2,044,592
|
|||||||||
Supplemental Cash
Flow Disclosures:
|
||||||||||||
Cash
paid during period for interest
|
$ |
111
|
-
|
$ |
-
|
|||||||
Cash
paid during period for taxes
|
$ |
800
|
800
|
$ |
-
|
|||||||
Acquisition
cost:
|
Estimate
useful life (year)
|
|
2007
|
2006
|
||
Production
Equipment
|
3
to
5
|
|
|
US$
|
93,315
|
93,315
|
Production
Clean room
|
10
|
|
|
78,261
|
56,917
|
|
Leasehold
improvement
|
10
|
|
|
188,980
|
185,482
|
|
Office
equipment
|
3
to
5
|
|
|
4,311
|
3,057
|
|
Computer
|
3
|
|
|
2,668
|
2,668
|
|
|
|
|
|
|
|
|
Subtotal
|
|
|
|
367,535
|
341,439
|
|
Less
accumulated depreciation
|
|
|
|
(2,212)
|
(882)
|
|
Total
|
|
|
|
US$
|
365,323
|
340,557
|
As
of September 30 , 2007
|
|
|||
|
|
|
|
|
Deferred
tax assets:
|
|
|
||
Net
operating tax carry forwards
|
|
$
|
1,657,140
|
|
Other
|
|
|
-0-
|
|
Gross
deferred tax assets
|
|
|
1,657,140
|
|
Valuation
allowance
|
|
|
(1,657,140)
|
|
|
|
|
|
|
Net
deferred tax assets
|
|
$
|
-0-
|
As
of September 30 , 2006
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Deferred
tax assets:
|
|
|
|
|
Net
operating tax carry forwards
|
|
$
|
853,117
|
|
Other
|
|
|
-0-
|
|
Gross
deferred tax assets
|
|
|
853,117
|
|
Valuation
allowance
|
|
|
(853,117
|
)
|
|
|
|
|
|
Net
deferred tax assets
|
|
$
|
-0-
|
|
Due
Date
|
Principal
Amount
|
|
October
25, 2008
|
$3620
|
|
October
19, 2008
|
$10,000
|
|
November
9, 2008
|
$14000
|
|
October
25, 2008
|
$19,500
|
|
October
12, 2008
|
$28,000
|
|
November
2, 2008
|
$31,300
|
Ending
September 30
|
Amounts
|
||
|
2008
|
$
241,611
|
|
|
2009
|
248,864
|
|
|
2010
|
234,377
|
|
2011
|
42,614
|
||
Total
|
$
767,466
|
|
|
Number
of
|
|
|
|
|
Shares
|
|
|
As
of September 30, 2007:
|
|
|
|
|
|
|
|
|
|
Granted
|
|
|
1,454,772
|
*
|
Remaining
shares available for issuance under the Plan as of
September 30, 2007
|
|
|
45,228
|
|
|
|
Number
of
|
|
|
|
Shares
|
|
As
of September 30, 2007:
|
|
|
|
|
|
|
|
Granted
|
|
1.198.540
|
|
|
|
|
|
Remaining
shares available for issuance under the Plan as of September 30,
2007
|
|
301,460
|
|
Due
Date
|
Principal
Amount
|
||
October
25, 2008
|
$3620
|
||
October
19, 2008
|
$10,000
|
||
November
9, 2008
|
$14000
|
||
October
25, 2008
|
$19,500
|
||
October
12, 2008
|
$28,000
|
||
November
2, 2008
|
$31,300
|
Name
|
|
Age
|
|
Position
|
|
David
R. Koos
|
|
49
|
|
Chairman
of the Board of Directors, President, CEO, Secretary, and Acting
CFO
|
|
Brian
Pockett
|
|
53
|
|
Vice
President and COO, Director
|
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Chairman,
President, CEO and Acting CFO
|
Bio-Matrix
Scientific Group,
Inc.
|
June
14, 2006 (Chairman) to Present
June
19, 2006 (President, CEO and Acting CFO)
June
19, 2006(Secretary) to Present
|
Chairman,
Chief Executive Officer, Secretary &Acting Chief Financial
Officer
|
Frezer
Inc.
|
May
2, 2005 to February
2007
|
Chairman,
Chief Executive Officer, Secretary &Acting Chief Financial
Officer
|
BMXP
Holdings, Inc.
BMSG
|
December
6, 2004 to Present
|
Managing
Director & President
|
Cell
Source Research Inc.
|
December
5, 2001 to Present
|
Managing
Director & President
|
Venture
Bridge Inc.
|
November
21, 2001 to Present
|
Member
of the Board of Directors, Chief Financial Officer &
Secretary
|
Cell
Bio-Systems Inc.
(New
York)
|
July
17, 2003 to December 1, 2003
|
Registered
Representative
|
Amerivet
Securities Inc.*
|
March
31, 2004 to Present
(Previously
employed: November, 2000 to
May,2002)
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Vice
President, COO and Director
|
Bio-Matrix
Scientific Group, Inc.
|
June
19, 2006 (Vice President and COO) to Present
June
14, 2006 (Director) to Present
|
Managing
Director & Chief Operating Officer
|
Frezer
Inc.
|
May
2, 2005 to February 2007
|
Managing
Director & Chief Operating Officer
|
BMXP
Holdings, Inc.
BMSG
|
December
6, 2004 to Present
|
Business
Development Consultant
|
Cell
Bio-Systems Inc.
(New
York)
|
April
1, 2003 to November 30, 2004
|
Sales
& Marketing Consultant
|
North
County Times
|
July
1, 2002 to March 15, 2003
|
Independent
Magazine Contractor
|
DaVinci
|
January
1, 2000 to June 30, 2002
|
Independent
Magazine Contractor
|
Digital
Diner
|
January
1, 2000 to June 30, 2002
|
Independent
Magazine Contractor
|
Shock
Waves
|
January
1, 2000 to June 30, 2002
|
Position:
|
Company
Name:
|
Employment
Dates:
|
Chief
Scientific Advisor
|
Bio-Matrix
Scientific Group, Inc.
|
August
9, 2006 to present
|
President
|
Frezer
Inc., San Diego , CA
|
May
2, 2005 to present
|
President
|
BMXP
Holdings, Inc.. San Diego, CA
|
March,
2005 to present
|
Consultant
in Biotechnology
|
Self
employed, Tarpon Springs FL
|
July,
2004 to March, 2005
|
Laboratory
and Scientific Director
|
Cryo-Cell
International Inc, Clearwater, FL
|
April,
1999 to June, 2004
|
SUMMARY
COMPENSATION TABLE
|
|
|
|||||||
Name
and principal position
|
Year
|
Salary($)
|
Bonus($)
|
Stock
Awards($) (a)
|
Option
Awards($)
|
Non-Equity
Incentive
Plan
Compensation
($)
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other
Compensation
($)
|
Total
($)
|
Dr.
David Koos
Chairman,
CEO and President
|
October
1, 2005
to
September 30,
2006
|
0
|
0
|
$292,500
|
0
|
0
|
0
|
0
|
$292,500
|
Mr.
Brian Pockett
Vice
President,
COO
and Director
|
October
1, 2005
to
September 30,
2006
|
0
|
0
|
$292,500
|
|
|
0
|
0
|
$292,500
|
SUMMARY
COMPENSATION TABLE
|
|
|
|||||||
Name
and principal position
|
Year
|
Salary($)
|
Bonus($)
(b)
|
Stock
Awards($)
(c)
|
Option
Awards($)
|
Non-Equity
Incentive
Plan
Compensation
($)
|
Nonqualified
Deferred
Compensation
Earnings
($)
|
All
Other
Compensation
($)
(d)
|
Total
($)
|
Dr.
David Koos
Chairman,
CEO and President
|
October
1, 2006
to
September 30,
2007
|
$10,000*
|
$8,000
|
$197,600
|
$4,446
|
$220,046
|
|||
Mr.
Brian Pockett
Vice
President,
COO
and Director
|
October
1, 2006
to
September 30,
2007
|
$49,000
|
$6,400
|
$76,550
|
$12,800
|
$144,750
|
Title
of Class
|
Name
and Address of Beneficial Owner
|
Amount
and Nature of Beneficial Owner
|
Percent
of Class
|
Common
|
David
R. Koos (a)(b)
C/o
Bio-Matrix Scientific Group, Inc
8885
REHCO RD.SAN DIEGO CA92121
|
13,206,955
|
56.45%
|
Common
|
Brian
Pockett
(a)
C/o
Bio-Matrix Scientific Group, Inc
8885
REHCO RD.SAN DIEGO CA92121
|
1,766,720
|
759%
|
Common
|
BMXP
Holdings Shareholder Business Trust
1010
University Ave #40, San Diego, CA 92103
|
11,462,570
|
48.99%
|
Common
|
All
Officers and Directors
As
a
Group(a)(b)(c)
|
13,378,915
|
57.85%
|
EXHIBIT
NUMBER
|
|
DESCRIPTION
|
|
|
|
|
|
31.1
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
32.1
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT
|
|
31.2
|
|
CERTIFICATION
BY CEO PURSUANT TO SECTION 302 OF SARBANES OXLEY ACT
|
|
32.2
|
|
CERTIFICATION
BY CFO PURSUANT TO SECTION 906 OF SARBANES OXLEY ACT
|
|
|
|
|
Period
beginning
Oct
1, 2006
and
ending
September
30,
2007
|
|
|
|
|
|
|
|
Audit
Fees
|
|
$
|
11,000
|
|
Audit
Related Fees
|
|
4,500
|
||
Tax
Fees
|
|
|
|
|
All
Other Fees
|
|
|
|
|
|
|
|
|
|
|
|
$
|
15,500
|
|
|
|
Period
beginning Oct1,2005 and ending September 30, 2006
|
|
|
|
|
|
|
|
Audit
Fees
|
|
$
|
5800
|
|
Audit
Related Fees
|
|
|
4670
|
|
Tax
Fees
|
|
|
0
|
|
All
Other Fees
|
|
|
75
|
|
|
|
|
|
|
|
|
$
|
10545
|
|
|
By:
|
/s/ David
R. Koos
|
|
|
|
David
R. Koos
|
|
|
|
Chairman,
CEO and President
|
|